Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2209–2232 of 2,430 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Learning Disorders Clear all

Conditions: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised, Hospitalization, Child, Hospitalized
Interventions: Nirmatrelvir, Ritonavir, Placebo for nirmatrelvir; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Cooperstown, New York • New York, New York

Conditions: Type 2 Diabetes
Interventions: iCOPE Intervention group; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 3
States / cities: Baltimore, Maryland

Conditions: PreDiabetes
Interventions: Diabetes Prevention Program (DPP), Community-Supported Agriculture (CSA), Community Health Worker support (CHW); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Sudden Cardiac Arrest
Interventions: Machine learning-guided cardiac arrest prediction device; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Lyme Disease
Interventions: VLA15, Placebo; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 7 Years and older
Enrollment: 1,712 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 19
States / cities: Bangor, Maine • Worcester, Massachusetts • Flemington, New Jersey + 13 more

Conditions: Overweight and Obesity, Overweight, Obesity
Interventions: ADAPT; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 55 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Colorectal Cancer, Type 2 Diabetes
Interventions: Intervention Group (IG); Behavioral
Lead sponsor: Charles Drew University of Medicine and Science; Other
Eligibility: 35 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Interventions: BIIB059 (litifilimab); Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years and older
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 13
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 10 more

Conditions: PTSD, Generalized Anxiety Disorder, Major Depressive Disorder
Interventions: CAPS-5-R, Senseye DT; Diagnostic Test
Lead sponsor: Senseye, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 5
States / cities: Aurora, Colorado • Meridian, Idaho • Charleston, South Carolina + 2 more

Conditions: Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Interventions: Sigvotatug Vedotin, Pembrolizumab; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 714 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 84
States / cities: Fullerton, California • Golden, Colorado • Grand Junction, Colorado + 56 more

Conditions: Breast Cancer
Interventions: Breast Cancer Clinical Trials Education Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years and older · Female only
Enrollment: 1,065 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2015
U.S. locations: 2
States / cities: La Jolla, California • Vista, California

Conditions: Dyslipidemia, Hypertension, Obesity & Overweight
Interventions: Nutrition education and produce prescription card; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 2 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: EHMI, Nurse Educator + EHMI; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 920 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Brachial Plexus Birth Palsy, Erbs Palsy
Interventions: Pilot Training Protocol, Standard Training Protocol; Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: St. Petersburg, Florida • Baltimore, Maryland

Conditions: Obesity, Overweight and/or Obesity, Overweight, Drug Interaction
Interventions: PF-08653944, Acetaminophen; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: PTSD, Post Traumatic Stress Disorder
Interventions: L-DOPA, Placebo; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 50 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Austin, Texas • Madison, Wisconsin

Conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes
Interventions: PF-08653944, Placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 1,078 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 55
States / cities: Anaheim, California • Canoga Park, California • Cerritos, California + 45 more

Conditions: Gonorrhea, Chlamydia, Meningococcal Vaccines
Interventions: Trumenba Vaccine, MenACWY Vaccine; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 15 Years to 30 Years
Enrollment: 1,307,378 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Colon Cancer
Interventions: Diagnostic Test: EXPOSE assay（Small RNA-seq of exosomal miRNAs）, Diagnostic Test: EXPOSE RT-qPCR panel; Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Brain Care Score, Exercise, Hypertension, BMI
Interventions: Exercise Intervention to improve overall Brain Health; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 35 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: DLD
Interventions: VOCAB +; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 8 Years to 9 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Acute Kidney Injury
Interventions: Alert; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 2,046 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stuttering, Developmental, Aphasia, Primary Progressive
Interventions: Learning of non-native phoneme combinations: 6 training sessions, Learning of non-native phoneme combinations: 1 training session, Learning of novel multisyllabic nonwords, Anodal tDCS, Sham tDCS, Learning of non-native phoneme combinations: 8 training sessions; Behavioral · Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 6 Years and older
Enrollment: 278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Boston, Massachusetts • Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea
Interventions: Adherence to Sleep Apnea Treatment, Standard Care Group; Behavioral · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Comprehensive Informatics Framework for Comparative Effectiveness Research (CER) Dissemination

Integrating Cultural Aspects Into Diabetes Education

AI-guided Prediction and Treatment of Cardiac Arrest

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions

Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Breast Cancer Trials Education Program

Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth

Northwestern University and Access Community Health Network Medication Education Study

Pilot Test of Caregiver Training Protocol for Brachial Plexus Birth Injury

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

Improving Therapeutic Learning for PTSD

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer

An Exercise Intervention to Improve Overall Brain Health

Effect of Phonotactic Probability and Orthography on Vocabulary Learning

Learning Alerts for Acute Kidney Injury

Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome